132 related articles for article (PubMed ID: 21893044)
1. Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a.
Liu J; Hao DD; Zhang JS; Zhu YC
Biochem Biophys Res Commun; 2011 Sep; 413(2):342-7. PubMed ID: 21893044
[TBL] [Abstract][Full Text] [Related]
2. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
Wu Y; Wang YQ; Wang BX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hydrogen sulfide (H
Wu Y; Guo YY; Zhang YY; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
[TBL] [Abstract][Full Text] [Related]
4. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes.
Sun YG; Cao YX; Wang WW; Ma SF; Yao T; Zhu YC
Cardiovasc Res; 2008 Sep; 79(4):632-41. PubMed ID: 18524810
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
8. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.
Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD
Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952
[TBL] [Abstract][Full Text] [Related]
9. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression.
Wang C; Wang S; Zhao P; Wang X; Wang J; Wang Y; Song L; Zou Y; Hui R
J Cell Biochem; 2012 Jun; 113(6):2040-6. PubMed ID: 22275134
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes.
Kesherwani V; Nandi SS; Sharawat SK; Shahshahan HR; Mishra PK
Mol Cell Biochem; 2015 Jun; 404(1-2):241-50. PubMed ID: 25763715
[TBL] [Abstract][Full Text] [Related]
11. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
12. miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B; Chen S; George B; Feng Q; Chakrabarti S
Diabetes Metab Res Rev; 2010 Jan; 26(1):40-9. PubMed ID: 20013939
[TBL] [Abstract][Full Text] [Related]
13. Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation.
Huang L; Xi Z; Wang C; Zhang Y; Yang Z; Zhang S; Chen Y; Zuo Z
Sci Rep; 2016 Feb; 6():20105. PubMed ID: 26830171
[TBL] [Abstract][Full Text] [Related]
14. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion.
Sun WH; Liu F; Chen Y; Zhu YC
Biochem Biophys Res Commun; 2012 May; 421(2):164-9. PubMed ID: 22503984
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
Feng B; Chen S; Chiu J; George B; Chakrabarti S
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1119-26. PubMed ID: 18413674
[TBL] [Abstract][Full Text] [Related]
17. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
18. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene.
Sowa N; Horie T; Kuwabara Y; Baba O; Watanabe S; Nishi H; Kinoshita M; Takanabe-Mori R; Wada H; Shimatsu A; Hasegawa K; Kimura T; Ono K
J Cell Biochem; 2012 Nov; 113(11):3455-65. PubMed ID: 22678827
[TBL] [Abstract][Full Text] [Related]
20. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
Nakagawa O; Ogawa Y; Itoh H; Suga S; Komatsu Y; Kishimoto I; Nishino K; Yoshimasa T; Nakao K
J Clin Invest; 1995 Sep; 96(3):1280-7. PubMed ID: 7657802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
